Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
Q9HBA0	59341	TRPV4 VRL2 VROAC	Metatropic dysplasia		Phosphorylation	N	Y91	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	Y110	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Liver cancer		Phosphorylation	N	Y110	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	Y110	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Uterine cancer		Phosphorylation	N	Y110	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	T112	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	T112	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	Y113	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	Y113	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S134	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Distal spinal muscular atrophy		Phosphorylation	N	S134	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Stomach adenocarcinoma		Phosphorylation	N	S134	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Uterine carcinosarcoma		Phosphorylation	N	S134	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Distal spinal muscular atrophy		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Head and neck squamous cell carcinoma		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Rectum adenocarcinoma		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Uterine corpus endometrial carcinoma		Phosphorylation	N	S162	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	T175	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Distal spinal muscular atrophy		Phosphorylation	N	T175	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	T175	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S189	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Skin cutaneous melanoma		Phosphorylation	N	S189	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Metatropic dysplasia		Ubiquitination	N	K192	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Metatropic dysplasia		Ubiquitination	N	K197	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Bladder urothelial carcinoma		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Distal spinal muscular atrophy		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Hepatocellular carcinoma		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Prostate adenocarcinoma		Phosphorylation	N	Y253	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S319	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	T335	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Head and neck squamous cell carcinoma		Phosphorylation	N	T335	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Metatropic dysplasia		Phosphorylation	N	T335	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Spondyloepimetaphyseal dysplasia		Phosphorylation	N	T335	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Ubiquitination	N	K344	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Inborn genetic diseases		Ubiquitination	N	K344	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Metatropic dysplasia		Ubiquitination	N	K344	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Distal spinal muscular atrophy		Phosphorylation	N	Y411	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y411	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	T505	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	Y508	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	Y805	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	T813	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S823	
Q9HBA0	59341	TRPV4 VRL2 VROAC	Charcot-Marie-Tooth disease		Phosphorylation	N	S824	
